Entity Name: | REVITALID PHARMACEUTICAL CORP. |
Jurisdiction: | FLORIDA |
Filing Type: | Foreign Profit |
Status: |
Inactive
The business entity is inactive. This status may signal operational issues or voluntary closure, raising concerns about the business's ability to repay loans and requiring careful risk assessment by lenders. |
Date Filed: | 12 Feb 2019 (6 years ago) |
Date of dissolution: | 27 Sep 2024 (7 months ago) |
Last Event: | REVOKED FOR ANNUAL REPORT |
Event Date Filed: | 27 Sep 2024 (7 months ago) |
Document Number: | F19000000759 |
FEI/EIN Number |
26-0010983
Federal Employer Identification (FEI) Number assigned by the IRS. |
Address: | 400 CROSSING BLVD, BRIDGEWATER, NJ, 08807, US |
Mail Address: | 400 CROSSING BLVD, BRIDGEWATER, NJ, 08807, US |
Place of Formation: | DELAWARE |
Name | Role | Address |
---|---|---|
BURGSTAHLER DAVID | Director | 65 East 55th Street, New York, NY, 10022 |
VENKATARAMAN SRIRAM | Director | 400 CROSSING BLVD, BRIDGEWATER, NJ, 08807 |
KLEIN CHRISTOPHER | Secretary | 400 CROSSING BLVD, BRIDGEWATER, NJ, 08807 |
Sielecki Daniel | Director | 400 CROSSING BLVD, BRIDGEWATER, NJ, 08807 |
Sielecki Carlos | Director | 400 CROSSING BLVD, BRIDGEWATER, NJ, 08807 |
Vergez Juan | Director | 400 CROSSING BLVD, BRIDGEWATER, NJ, 08807 |
CORPORATION SERVICE COMPANY | Agent | - |
Event Type | Filed Date | Value | Description |
---|---|---|---|
REVOKED FOR ANNUAL REPORT | 2024-09-27 | - | - |
NAME CHANGE AMENDMENT | 2023-03-30 | REVITALID PHARMACEUTICAL CORP. | - |
Name | Date |
---|---|
Name Change | 2023-03-30 |
ANNUAL REPORT | 2023-03-12 |
ANNUAL REPORT | 2022-04-20 |
ANNUAL REPORT | 2021-04-05 |
ANNUAL REPORT | 2020-04-30 |
Foreign Profit | 2019-02-12 |
Date of last update: 03 Apr 2025
Sources: Florida Department of State